Clinical Study

A Phase Ib Multi-Cohort Trial Of Mk-3475 (Pembrolizumab) In Subjects With Hematologic Malignancies

Posted Date: Mar 16, 2016

  • Investigator: Trisha Wise-Draper
  • Co-Investigator: Belinda Tuttle
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

This is a research study to test an investigational drug, pembrolizumab, which has been approved for use in certain types of adult melanoma and lung cancer however it has not been approved in any other cancers.

Criteria:

To Be Eligible To Participate Patients Must Have Cancer Of The Blood, Bone Marrow, Or Lymph Nodes.

Keywords:

Mk3475-013, Hematology, Cancer, Phase I, Keynote

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant